Citadel Advisors’s Carlsmed CARL Stock Holding History
Bought
Maintained
Sold
Other funds holding CARL
Citadel Advisors's CARL Position: Q3 2026 in Review
Citadel Advisors reduced its Carlsmed (CARL) stake by 33% in Q3 2026, selling an estimated $473K and leaving 67,706 shares worth $953K. The position accounts for ﹤0.01% of the portfolio, ranked #8593.
Citadel Advisors first reported a position in CARL in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.47M in Q3 2025. 87 funds tracked by Wall St. Rank hold CARL as of Q3 2026.
- Citadel Advisors held 67,706 shares of Carlsmed worth $953K as of Q3 2026.
- Citadel Advisors sold 34,020 Carlsmed shares in Q3 2026, an estimated $473K.
- Carlsmed made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #8593 holding.
- Citadel Advisors first reported a position in Carlsmed in Q3 2025 and has held it in 4 quarters since.
- Citadel Advisors's Carlsmed position peaked at $1.47M in Q3 2025.
- 87 funds tracked by Wall St. Rank held Carlsmed as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.